Interestingly, targeting the Kv2.1-syntaxin interaction with a peptide mimicking the syntaxin-1A binding domain of Kv2.1 ameliorated cell death in an in vivo model of ischemic stroke (Yeh et al., 2017). The gene discussed is KCNB1; the disease is ischemic stroke.